Avid Radiopharmaceuticals, Inc. to Present Clinical Trial Advances in Molecular Imaging of Pathologic Targets Associated with Alzheimer’s Disease, Dementia with Lewy Bodies and Diabetes at SNM Meeting June 6-9th

PHILADELPHIA--(BUSINESS WIRE)--Avid Radiopharmaceuticals, Inc. announced today that seven oral presentations and three poster presentations will be made about the company’s PET imaging programs in three focus areas — Alzheimer’s disease (“AD”), Dementia with Lewy Bodies (“DLB”) and Diabetes — at the upcoming 2010 Annual Society of Nuclear Medicine (SNM) meeting in Salt Lake City, Utah, beginning Sunday, June 6, 2010.